Greenwich LifeSciences (GLSI) Amortizatization of Intangibles (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Amortizatization of Intangibles of $876.0 for Q2 2025, down 2.99% on a QoQ basis from $903.0 in Q1 2025, and down 2.99% year-over-year from $903.0 in Q2 2024.
Greenwich LifeSciences (GLSI) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $876.0 for Q2 2025.
- Quarterly Amortizatization of Intangibles fell 2.99% year-over-year to $876.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $1779.0 (down 50.75% YoY) and the FY2025 annual result came in at $1779.0, down 50.75% from the prior year.
- Amortizatization of Intangibles was $876.0 for Q2 2025 at Greenwich LifeSciences, down from $903.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $903.0 in Q1 2021 and bottomed at $876.0 in Q2 2025.
- A 5-year average of $901.5 and a median of $903.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles advanced 0.22% — and 2025, when it dropped 2.99%.
- Greenwich LifeSciences' Amortizatization of Intangibles stood at $903.0 in 2021, then changed by 0.0% to $903.0 in 2022, then changed by 0.0% to $903.0 in 2023, then changed by 0.0% to $903.0 in 2024, then dropped by 2.99% to $876.0 in 2025.
- Business Quant data shows GLSI's Amortizatization of Intangibles at $876.0 in Q2 2025, $903.0 in Q1 2025, and $903.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Greenwich LifeSciences | 183.67 Mn | 183.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 876.00 |
| Jun 30, 2025 | 876.00 |
| Mar 31, 2025 | 903.00 |
| Mar 31, 2025 | 903.00 |
| Dec 31, 2024 | 903.00 |
| Dec 31, 2024 | 903.00 |
| Sep 30, 2024 | 903.00 |
| Sep 30, 2024 | 903.00 |
| Jun 30, 2024 | 903.00 |
| Jun 30, 2024 | 903.00 |
| Mar 31, 2024 | 903.00 |
| Mar 31, 2024 | 903.00 |
| Dec 31, 2023 | 903.00 |
| Dec 31, 2023 | 903.00 |
| Sep 30, 2023 | 903.00 |
| Sep 30, 2023 | 903.00 |
| Jun 30, 2023 | 903.00 |
| Jun 30, 2023 | 903.00 |
| Mar 31, 2023 | 903.00 |
| Mar 31, 2023 | 903.00 |